Home Cart Sign in  
Chemical Structure| 1646839-59-9 Chemical Structure| 1646839-59-9

Structure of Tamnorzatinib
CAS No.: 1646839-59-9

Chemical Structure| 1646839-59-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ONO-7475 is a potent and selective inhibitor of active novel Axl/Mer tyrosine kinase with IC50 values of 0.7nM and 1nM, respectively. It potently arrested growth and induced apoptosis in acute myeloid leukemia with internal tandem duplication mutation of FMS-like tyrosine kinase 3.

Synonyms: ONO-7475

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tamnorzatinib

CAS No. :1646839-59-9
Formula : C32H26N4O6
M.W : 562.57
SMILES Code : O=C(C1=CC2=C(N(C3=CC=CC=C3)C1=O)CCCC2=O)NC4=NC=C(OC5=CC=NC6=CC(OC)=C(OC)C=C56)C=C4
Synonyms :
ONO-7475
MDL No. :MFCD32689448
InChI Key :WHMMKPWGWNYYFE-UHFFFAOYSA-N
Pubchem ID :90645873

Safety of Tamnorzatinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Tamnorzatinib

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MOLM13 cells 10 nM or 50 nM 48 hours Evaluate the effect of ONO-7475 alone or in combination with ABT-199 on FLT3-ITD AML cells. Results showed that the combination of 50 nM ONO-7475 with 30 nM ABT-199 resulted in >99% reduction in viability in MOLM13 cells. PMC9152975
MV4;11 cells 10 nM 48 hours ONO-7475 significantly reduced the viability of FLT3-ITD AML cells and induced apoptosis. PMC5709104
MOLM13 cells 10 nM 48 hours ONO-7475 significantly reduced the viability of FLT3-ITD AML cells and induced apoptosis. PMC5709104
MV4;11 cells 10 nM or 50 nM 72 hours Evaluate the effect of ONO-7475 alone or in combination with ABT-199 on FLT3-ITD AML cells. Results showed that the combination of 10 nM ONO-7475 with 30 nM ABT-199 nearly eliminated MV4;11 cells (~98% reduction of viable cells). PMC9152975
Vascular Smooth Muscle Cells (VSMCs) 0.1 µM ONO-7475 effectively inhibited csEV-mediated proliferation and migration of VSMCs PMC10104856

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice FLT3-ITD AML xenograft model Oral gavage 10 mg/kg Five days a week, continuous treatment Evaluate the effect of ONO-7475 alone or in combination with ABT-199 on FLT3-ITD AML xenograft models. Results showed that ONO-7475 alone significantly extended the survival of mice (average survival 22 days), while the combination therapy was most effective (average survival 35 days). PMC9152975
NSG mice Human FLT3-ITD mutant murine xenograft model Oral 6 mg/kg and 20 mg/kg Once daily until the end of the experiment ONO-7475 significantly prolonged the survival of mice and blocked leukemia cell infiltration in the liver. PMC5709104

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.78mL

0.36mL

0.18mL

8.89mL

1.78mL

0.89mL

17.78mL

3.56mL

1.78mL

References

 

Historical Records

Categories